Chromosome 7 genes AKT and PTEN are used as prognostic markers for NSCLC [89], suggesting that chromosome 7 genes that have been identified across stages of LUAD as methylated can be considered for prognostic significance in LUAD. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.